EGFR and non-small cell lung carcinoma: Non-small cell lung cancer (NSCLC) comprises over 85% of lung cancer cases [3, 4], with epidermal growth factor receptor (EGFR) mutations occurring in 9–46% of NSCLC cases [5, 6].